Found: 2
Select item for more details and to access through your institution.
A decreased ratio between serum levels of the antagonistic angiopoietins 1 and 2 indicates tumour progression of malignant melanoma.
- Published in:
- Archives of Dermatological Research, 2012, v. 304, n. 5, p. 397, doi. 10.1007/s00403-012-1228-2
- By:
- Publication type:
- Article
Sorafenib and everolimus in patients with advanced solid tumors and KRAS‐mutated NSCLC: A phase I trial with early pharmacodynamic FDG‐PET assessment.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 14, p. 4991, doi. 10.1002/cam4.3131
- By:
- Publication type:
- Article